GENELUX Corp

GNLX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.1B · 26 employees
64
SEC Filings
$2.91
Close 2026-07-15
26
Employees

Business Summary

PART I A. Overview Genelux is a late clinical-stage biopharmaceutical company focused on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat tumor types. Our clinical and preclinical product candidates are intended to selectively kill tumor cells and induce a robust immune response against a patients tumor neoantigens. Importantly, our oncolytic immunotherapy product candidates are off-the-shelf personalized immunotherapies....

Latest Stock Quote

GNLX 2026-07-15 $2.91 O:$2.91 H:$2.93 L:$2.83 Vol:0.2M VWAP:$2.8758
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001493152-26-011616EDGAR99K words
2025-03-282024-12-310001641172-25-001184EDGAR—
2024-03-292023-12-310001493152-24-011946EDGAR—
2023-03-292022-12-310001193125-23-083829EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001493152-26-037667EDGAR—
2025-11-052025-09-300001493152-25-020874EDGAR29K words
2025-08-072025-06-300001641172-25-022583EDGAR—
2025-05-062025-03-310001641172-25-008838EDGAR—
2024-11-142024-09-300001493152-24-045790EDGAR—
2024-08-142024-06-300001493152-24-032145EDGAR—
2024-05-092024-03-310001493152-24-018436EDGAR—
2023-11-142023-09-300001493152-23-041151EDGAR—
2023-08-142023-06-300001493152-23-027998EDGAR—
2023-05-152023-03-310001493152-23-016832EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-190001493152-26-011649EDGAR23K words
2026-02-020001493152-26-004755EDGAR—
2026-01-080001493152-26-000989EDGAR—
2026-01-050001493152-26-000270EDGAR—
2026-01-020001493152-26-000115EDGAR—
2025-09-030001641172-25-026390EDGAR—
2025-03-250001641172-25-000642EDGAR—
2025-03-250001641172-25-000528EDGAR—
2025-02-030001493152-25-004554EDGAR—
2024-11-080001493152-24-044258EDGAR—

64 total filings indexed. 40 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Company Identity

CIK0001231457
TickerGNLX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.genelux.com
Listed2023-01-26

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: aa02026f6f917dd17e8053c39cce1be1412a74eae37768efa055857dd600000a
parent: 210245fab96d31015818f636a4fdd250f23040a86bec1a6d9b8a1a81ba31b567
content hash: 859fae5371759818bbe64ab35ad673f560d5b185cbf4b1d3d111c32d6151dc31
signed: 2026-08-13T19:03:38.111Z
sources: 14 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up GNLX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on GNLX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/GNLX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.